Project Grant R21AA031366
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$187K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $235,750 Project Grant (CFDA 93.273 - Alcohol Research Programs) to Rhode Island Hospital, a division of Lifespan Corporation, to conduct research on detecting and monitoring alcohol-related white matter brain pathology using serum exosomes. The key objective is to develop an efficient, non-invasive method to assess the effects of alcohol consumption and treatment interventions on white matter degeneration. The...
This federal Project Grant award, valued at $517,248.00, was awarded on July 8, 2024 by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program. The grant supports research to explore the mechanisms by which acute and chronic ethanol exposure regulate a specific pathway involving norepinephrine, astrocytes, and dopamine neurons in the ventral periaqueductal gray region of the brain. This research aims to understand...
This federal Project Grant award for $594,784.00, awarded on July 15, 2024 by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), will fund a multi-omic study of alcohol use disorder (AUD) in the human brain. The research team from Yale University will perform postmortem analyses of brain tissue samples from 341 subjects, including 100 with AUD, 132 with major depressive disorder, and 109 neurotypical controls. The study aims to...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports a comprehensive research study to investigate the impact of chronic alcohol consumption on the progression of Alzheimer's disease (AD). The total award amount is $151,869.00 over a 2-year period from May 1, 2025 to April 30, 2027. The key objectives of this study are to: 1) assess the influence of chronic ethanol...
The University of California Irvine was awarded a $412,125 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The grant funds a research project to comprehensively determine how alcohol consumption alters the metabolism of critical organs, which can contribute to alcohol-induced organ damage. The project will employ arteriovenous metabolomics to quantitatively measure the dynamic metabolic...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research to determine the role of microglia in alcohol use disorder (AUD) and Alzheimer's disease (AD) pathology. The $223,531 award will fund the development of novel 3D reciprocal brain circuits using human iPSC-derived neurons and microglia to study how alcohol-induced changes in microglial metabolism and function impact neuronal...
This federal Project Grant award was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to The Regents of the University of California, San Francisco (UCSF). The $499,442 award, effective August 20, 2024 through July 31, 2027, will fund research to investigate the role of Brain-Derived Neurotrophic Factor (BDNF) signaling in the ventral hippocampus and its impact on the acute anxiolytic and social effects of alcohol, as...
This $238,445 Project Grant award was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award supports research to elucidate the mechanism and significance of translatome (mRNA translation) alteration as a critical pathophysiology of alcoholic fatty liver (AFL) disease. The research aims to determine the molecular mechanism of dysregulated translatome in terminally differentiated human...
This $374,598 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports research to investigate the impact of alcohol consumption on RNA modifications and their potential role in the development and progression of alcohol-associated liver disease (ALD). The key objectives of this 2-year project are to: 1) Map the site-specific chemical modifications on different types of RNAs isolated...
This $517,379 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports research to investigate the role of KDM5 demethylases in alcohol-associated liver disease (ALD) development and resolution. The project aims to determine how these epigenetic regulators in hepatocytes mediate cellular crosstalk that promotes ALD progression and fibrosis, as well as define the mechanisms by...